LFSC ETF
F/m Emerald Life Sciences Innovation ETF
LFSC ETF Overview
LFSC ETF (F/m Emerald Life Sciences Innovation ETF) is managed by Emerald ETF with $113.7M in net assets. LFSC expense ratio is 0.54%, holding 80 positions across sectors including Health Care, Financials, Information Technology. Inception date: 2024-10-30.
LFSC performance shows a YTD return of 22.54%. The 1-year return is 49.44%.
LFSC top holdings include Travere Therapeutics Inc (8.9%), Corcept Therapeutics Inc (6.9%), Spyre Therapeutics Inc (6.7%), Livanova Plc Ordinary Shares (6.5%), Cogent Biosciences Inc (6.4%). Go to all LFSC holdings, LFSC sectors, or LFSC dividends.
LFSC can be compared against other funds. Use LFSC overlap to find shared positions, or LFSC vs another fund for a side-by-side view. LFSC alternatives are available via the screener, along with tax-loss harvesting opportunities.